- Deepa Arora
- Vice President, Pharmacovigilance & Global Head of Drug Safety & Risk Managment
- Lupin Pharmaceuticals
Dr Deepa Arora is a Physician with more than 20 years of experience in pharma industry and academia. She has led different functions including drug safety for products under clinical development as well as post approval for regulated markets, clinical development of biosimilars of US FDA and EMEA, clinical operations, medical information, post authorization studies and registries.
Dr Arora set-up integrated, regulatory compliant and cost-efficient end to end Pharmacovigilance systems for Lupin and Wockhardt. Under her able leadership, teams successfully cleared PADE and GVP inspections conducted by various regulatory authorities. She’s also the author of the book- “Pharmacovigilance- An Industry Perspective.” Her forte is a clear understanding the regulations and expectations of regulatory authorities required for compliant PV systems and she also ensures compliance with safety aspects scrutinized during GMP and GCP inspections.
She has worked in Pharma companies like Lupin, Wockhardt and Dabur and also worked in CROs as Clinical Operations Lead and as Project Manager.